# The kidney outcome in FLOW

> Kidney outcomes, examined at MedWell Med Spa — MedWell Med Spa follows FLOW's kidney outcome in people with type 2 diabetes and chronic kidney disease, keeping its composite and population in view.

**The FLOW trial**

Well can mean something preserved. This trial gives that hope a specific population and a demanding outcome.

## The FLOW population

In existing illness, preservation seems a more worthwhile ambition to me than transformation: something valuable continuing. In [FLOW, semaglutide reduced major kidney-disease events versus placebo in people with type 2 diabetes and chronic kidney disease](https://pubmed.ncbi.nlm.nih.gov/38785209/). The trial enrolled 3,533 people with both conditions.

That both matters. It is easy to imagine a general kidney-health story after seeing a favourable result. The actual trial supplies a much more particular setting, and that particularity is part of what makes the result useful. Inflating the finding into a general wellness claim would cost the specificity that persuades me.

[The reported hazard ratio for the primary kidney composite was 0.76, with a 95% confidence interval of 0.66-0.88: a 24% lower risk versus placebo](https://pubmed.ncbi.nlm.nih.gov/38785209/). The result's importance, to my mind, lies in those consequential outcomes among people already living with illness.

![An adult's hands hold an opened kidney teaching model above a white worktable.](images/kidney-teaching-model.webp)

*An imagined teaching-model scene for the kidney essay, with no study participant or treatment depicted.*

## The composite outcome

[FLOW's primary outcome combined kidney failure, a decline of at least 50% in eGFR, or death from kidney or cardiovascular causes](https://pubmed.ncbi.nlm.nih.gov/38785209/). A composite gathers several outcomes into the trial's main comparison. Here, it includes death as well as kidney failure and the eGFR decline.

Describing the whole finding as a simple improvement in a kidney number seems too small an account to me. Its subjects are more consequential, and more varied. The reported comparison concerns their combination; it does not supply a separate 24% reduction for every component.

This is where well becomes a demanding word for me. An easier day, fewer cardiovascular events and a kidney composite can all matter, yet each asks for its own account. The untidy collection seems a more honest account than a single flattering verdict. The [heart essay](/heart-record) adds another event record, while the [home page](/) returns to the different ambitions around growing and living well.

---

At MedWell Med Spa, published research about growing and living well occupies my attention; this editorial publication operates no medical business and provides no medical advice.